{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:16:32Z","timestamp":1788520592358,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.cmi.2015.11.004","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T16:59:43Z","timestamp":1448470783000},"page":"S15-S25","source":"Crossref","is-referenced-by-count":96,"special_numbering":"S1","title":["Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement"],"prefix":"10.1016","volume":"22","author":[{"given":"X.","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2015.11.004_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2015.11.004_bib2","series-title":"Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"10.1016\/j.cmi.2015.11.004_bib3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/JCM.25.9.1725-1729.1987","article-title":"In\u00a0vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone\u2013sulbactam combination","volume":"25","author":"Jones","year":"1987","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2015.11.004_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/039463201302600325","article-title":"Microbiological and molecular characterization of extreme drug-resistant carbapenemase-producing Klebsiella pneumoniae isolates","volume":"26","author":"Santino","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.cmi.2015.11.004_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10096-010-0921-3","article-title":"Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary","volume":"29","author":"Toth","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhin.2012.02.007","article-title":"Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae","volume":"81","author":"Naparstek","year":"2012","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2015.11.004_bib7","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/ajt.12424","article-title":"Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients","volume":"13","author":"Clancy","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.11.004_bib8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2015.11.004_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2012.09.008","article-title":"Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages","volume":"41","author":"Zarrilli","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2015.11.004_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/eri.09.108","article-title":"Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy","volume":"8","author":"Zavascki","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2015.11.004_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4161\/viru.2.2.15014","article-title":"The intrinsic resistome of Pseudomonas aeruginosa to beta-lactams","volume":"2","author":"Alvarez-Ortega","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.cmi.2015.11.004_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/fmb.09.45","article-title":"Stenotrophomonas maltophilia drug resistance","volume":"4","author":"Sanchez","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.cmi.2015.11.004_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2015.11.004_bib14","first-page":"401","article-title":"CHINET 2014 surveillance of bacterial resistance in China","volume":"15","author":"Hu","year":"2015","journal-title":"Chin J Infect Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2015.11.004_bib15","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","article-title":"Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005\u20132014","volume":"22","author":"Hu","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2015.11.004_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2015.09.015","article-title":"National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013","volume":"22","author":"Xu","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"47","key":"10.1016\/j.cmi.2015.11.004_bib17","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.47.19045-en","article-title":"Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe","volume":"13","author":"Souli","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2015.11.004_bib18","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/cid\/cis1043","article-title":"Public health risks of enterobacterial isolates producing extended-spectrum \u03b2-lactamases or AmpC \u03b2-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options","volume":"56","author":"Liebana","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2015.11.004_bib20","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/AAC.02373-13","article-title":"Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae","volume":"58","author":"Tumbarello","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib21","first-page":"739","article-title":"Adult hospital acquired pneumonia: a multicenter study on microbiology and clinical characteristics of patients from 9 Chinese cities","volume":"35","author":"Liu","year":"2012","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.cmi.2015.11.004_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jmii.2014.04.005","article-title":"Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 \u03b2-lactamase at a teaching hospital in Shanghai, China","volume":"48","author":"Li","year":"2015","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2015.11.004_bib23","first-page":"673","article-title":"A\u00a0case\u2013control study on the risk factors of pandrug-resistant Pseudomonas aeruginosa pneumonia","volume":"19","author":"Wei","year":"2009","journal-title":"Zhonghua Yi Yuan Gan Ran Xue Za Zhi"},{"key":"10.1016\/j.cmi.2015.11.004_bib24","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s10096-012-1629-3","article-title":"Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients","volume":"31","author":"Pena","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.diagmicrobio.2007.09.007","article-title":"Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes","volume":"60","author":"Tan","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib26","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/522998","article-title":"Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer","volume":"45","author":"Safdar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib27","article-title":"Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital","author":"Pien","year":"2013","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2015.11.004_bib28","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/jac\/dku168","article-title":"Combination therapy for carbapenem-resistant Gram-negative bacteria","volume":"69","author":"Paul","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib29","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1592\/phco.2005.25.10.1353","article-title":"Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options","volume":"25","author":"Obritsch","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2015.11.004_bib30","doi-asserted-by":"crossref","first-page":"e28177","DOI":"10.1371\/journal.pone.0028177","article-title":"Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B","volume":"6","author":"Lim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.11.004_bib31","first-page":"357","article-title":"Multiple combination bactericidal testing against pandrug resistant Pseudomonas aeruginosa","volume":"10","author":"Yang","year":"2010","journal-title":"Chin J Infect Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.diagmicrobio.2011.03.003","article-title":"Comparative in\u00a0vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU","volume":"70","author":"Sheng","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib33","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib34","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv200","article-title":"Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study","volume":"70","author":"Tumbarello","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase\u2013producing K.\u00a0pneumoniae: importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib36","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1469-0691.2011.03553.x","article-title":"Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?","volume":"17","author":"Daikos","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2015.11.004_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2014.02.015","article-title":"Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii","volume":"729","author":"Sun","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cmi.2015.11.004_bib38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijantimicag.2009.10.019","article-title":"Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2015.11.004_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijantimicag.2014.08.010","article-title":"Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China","volume":"45","author":"Jiang","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2015.11.004_bib40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2013.09.010","article-title":"Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria","volume":"43","author":"Pontikis","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2015.11.004_bib41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/527442","article-title":"Fosfomycin: use beyond urinary tract and gastrointestinal infections","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2334-11-109","article-title":"Activities of colistin\u2013andminocycline\u2013based combinations against extensive drug resistant Acinetobacterbaumannii isolates from intensive care unit patients","volume":"11","author":"Liang","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib43","first-page":"524","article-title":"In\u00a0vitro activities of polymyxin B in combination with other antimicrobials against pan-drug-resistant strains of Pseudomonas aeruginosa","volume":"37","author":"Liu","year":"2012","journal-title":"Chin J Antibiot"},{"key":"10.1016\/j.cmi.2015.11.004_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2004.10.002","article-title":"Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli","volume":"25","author":"Sader","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2015.11.004_bib45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/eri.11.24","article-title":"Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment","volume":"9","author":"Abbott","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2015.11.004_bib46","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/AAC.00072-12","article-title":"Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients","volume":"56","author":"Milne","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib47","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jac\/dks084","article-title":"Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies","volume":"67","author":"Cai","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib48","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/AAC.00264-10","article-title":"In\u00a0vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii","volume":"54","author":"Cai","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/653120","article-title":"Treatment of Acinetobacter infections","volume":"51","author":"Fishbain","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1473-3099(14)70850-3","article-title":"Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus","volume":"15","author":"Nation","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib52","first-page":"536","article-title":"In\u00a0vitro combination antimicrobial susceptibility testing on carbapenem-resistant Pseudomonas aeruginosa","volume":"37","author":"Wen","year":"2012","journal-title":"Chin J Antibiot"},{"key":"10.1016\/j.cmi.2015.11.004_bib53","first-page":"393","article-title":"Surveillance of bacterial resistance in Shanghai hospitals during 2006","volume":"7","author":"Zhu","year":"2007","journal-title":"Chin J Infect Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib54","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2012.12.014","article-title":"In\u00a0vitro activity of sulbactam in combination with imipenem, meropenem, panipenem or cefoperazone against clinical isolates of Acinetobacter baumannii","volume":"41","author":"Ji","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2015.11.004_bib55","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1089\/mdr.2012.0076","article-title":"In\u00a0vitro activity of minocycline alone and in combination with cefoperazone\u2013sulbactam against carbapenem-resistant Acinetobacter baumannii","volume":"18","author":"Pei","year":"2012","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2015.11.004_bib56","first-page":"2847","article-title":"Cefoperazone\u2013sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections","volume":"92","author":"Shi","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.cmi.2015.11.004_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diagmicrobio.2013.02.009","article-title":"Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011)","volume":"76","author":"Sader","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijantimicag.2012.09.005","article-title":"The emergence of clinical resistance to tigecycline","volume":"41","author":"Sun","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2015.11.004_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2008.11.006","article-title":"Tigecycline in combination with other antimicrobials: a review of in\u00a0vitro, animal and case report studies","volume":"34","author":"Entenza","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2015.11.004_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2014.01.006","article-title":"Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections","volume":"44","author":"Falagas","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2015.11.004_bib61","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.01232-12","article-title":"Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem\u2013cilastatin for treatment of hospital-acquired pneumonia","volume":"57","author":"Ramirez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib62","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/cc13858","article-title":"High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria","volume":"18","author":"De Pascale","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2015.11.004_bib63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/QCO.0b013e32833ae38b","article-title":"Multiresistant Acinetobacter baumannii infections: epidemiology and management","volume":"23","author":"Garnacho-Montero","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistion alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib65","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-013-0013-7","article-title":"Ceftazidime-avibactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination","volume":"73","author":"Zhanel","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2015.11.004_bib67","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/jac\/dks523","article-title":"Comparative study of the efficacy and safety of ceftazidime\/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, phase II trial","volume":"68","author":"Lucasti","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40265-013-0168-2","article-title":"Ceftolozane\/tazobactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination with activity against multidrug-resistant Gram-negative bacilli","volume":"74","author":"Zhanel","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2015.11.004_bib69","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1128\/AAC.00049-14","article-title":"Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane\u2013tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections","volume":"58","author":"Lucasti","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2015.11.004_bib70","first-page":"256","article-title":"Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.cmi.2015.11.004_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measure to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients","volume":"20","author":"Tacconelli","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2015.11.004_bib72","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/594129","article-title":"Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure","volume":"29","author":"Srinivasan","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2015.11.004_bib73","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/598194","article-title":"Colonization with multidrug-resistant Gram-negative bacteria: prolonged duration and frequent cocolonization","volume":"48","author":"O\u2019Fallon","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.004_bib74","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1113849","article-title":"Effect of daily chlorhexidine bathing on hospital-acquired infection","volume":"368","author":"Climo","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2015.11.004_bib75","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1086\/644751","article-title":"Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital","volume":"30","author":"Munoz-Price","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2015.11.004_bib76","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional proGram to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15009866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15009866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T05:02:21Z","timestamp":1653627741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15009866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":76,"alternative-id":["S1198743X15009866"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2015.11.004","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}